• Vaginal pH
  • Oncotype DX, Prostate Cancer
  • Celiac Disease Antibody Panel
  • Cytomegalovirus (CMV) Antibody, IgM
  • Immunoglobulin Subclass IgG4
  • Potassium, 24 Hour, Urine
  • Islet Cell (IA-2) Autoantibodies
  • Alveolar Rhabdomyosarcoma (ARMS) by Reverse Transcriptase PCR (RT-PCR)
  • Francisella tularensis Antibody, IgG, IgM
  • Epstein-Barr Virus (EBV), Real-Time PCR
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

References
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.